Leading The Global Fight Against Vaccine-Preventable Infectious Diseases Through Investment, Innovation And Partnerships

Over the course of the past two years, the healthcare industry and U.S. regulatory bodies have moved swiftly to better understand SARS-CoV-2 and how to best combat the evolving virus.